The utility of an antifos ribozyme in reversing cisplatin resistance in human carcinomas

Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia

1985 • 9,128 citations

Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene

1984 • 3,150 citations

Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor

1987 • 3,057 citations

Fos and jun: The AP-1 connection

1988 • 1,597 citations

Simple RNA enzymes with new and highly specific endoribonuclease activities

1988 • 1,118 citations

Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40

1987 • 762 citations

Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sites

1987 • 660 citations

DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in Xenografts

1989 • 645 citations

Fos-Associated Protein p39 Is the Product of the jun Proto-Oncogene

1988 • 643 citations

Transcriptional autoregulation of the proto-oncogene fos

1988 • 630 citations

Common DNA binding site for Fos protein complexesand transcription factor AP-1

1988 • 613 citations

Overexpression of Metallothionein Confers Resistance to Anticancer Drugs

1988 • 600 citations

Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters

1988 • 597 citations

Biological Catalysis by RNA

1986 • 496 citations

Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation.

1986 • 468 citations

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.

1986 • 374 citations

Growth Factors Regulate Transin Gene Expression by c- fos -Dependent and c- fos -Independent Pathways

1988 • 290 citations

Microinjection of fos-specific antibodies blocks DNA synthesis in fibroblast cells.

1988 • 266 citations

Viral and cellular fos proteins are complexed with a 39,000-dalton cellular protein.

1985 • 249 citations

Expression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: both Fos and Jun contact DNA directly.

1990 • 245 citations

Induction of fos RNA by DNA-damaging agents.

1989 • 209 citations

Molecular basis of cisplatin resistance in human carcinomas: model systems and patients.

1989 • 106 citations

fos/jun and Octamer-binding Protein Interact with a Common Site in a Negative Element of the Human c-myc Gene

1989 • 102 citations

Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells.

1988 • 98 citations

Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells.

1990 • 80 citations

Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene.

1990 • 77 citations

Incorporation of 3’-Azido-3’-deoxythymidine into Cellular DNA and Its Removal in a Human Leukemic Cell Line

1990 • 64 citations

Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT8 cells and circumvention by azidothymidine.

1989 • 63 citations

Biochemical and molecular properties of cisplatin-resistant A2780 cells grown in folinic acid.

1988 • 52 citations

Detection of drug resistance in human tumors by in vitro enzymatic amplification.

1988 • 39 citations

Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracil

1990 • 39 citations

Transfected human beta-polymerase promoter contains a ras-responsive element.

1990 • 34 citations

Expression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: Both Fos and Jun contact DNA directly

1990 • 24 citations

Potentiation of Azidothymidine Cytotoxicity in Cisplatin-resistant Human Ovarian Carcinoma Cells

1990 • 21 citations